Verified earnings results
BlossomHill Therapeutics Q2 2026 Earnings Results
Direct answer
BlossomHill Therapeutics reported Q2 2026 results on September 18, 2026.
Revenue was 0. EPS missed the estimate by 746.56%.
The result is verified against Verified earnings source.
Verified earnings source
Get free BlossomHill Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Earnings date
- September 18, 2026
- Reported timing
- Before the US market opens
- EPS estimate
- -1.0336
- Reported EPS
- -8.75
- Revenue
- 0
- EPS surprise
- EPS missed the estimate by 746.56%.
Explore related company data
Read the frequently asked questions.
When did BlossomHill Therapeutics report Q2 2026 earnings?
BlossomHill Therapeutics reported on September 18, 2026. The reported timing was before the us market opens.
What is the available EPS estimate for BlossomHill Therapeutics?
The verified record provides an EPS estimate of -1.0336.
Has BlossomHill Therapeutics reported the Q2 2026 result?
Revenue was 0. EPS missed the estimate by 746.56%.
Which source supports this BlossomHill Therapeutics earnings record?
The earnings record identifies Verified earnings source as its source. Missing values are not estimated.